{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:14:43Z","timestamp":1786990483266,"version":"build-2736575974"},"reference-count":272,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijcha.2024.101469","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T15:49:23Z","timestamp":1721749763000},"page":"101469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases"],"prefix":"10.1016","volume":"53","author":[{"given":"Owais Mohmad","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakeeb Ahmad","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra Bashir","family":"Nehvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissar Ahmad","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid Hamid","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Afzal","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7503","key":"10.1016\/j.ijcha.2024.101469_b0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"35","key":"10.1016\/j.ijcha.2024.101469_b0015","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/sj.onc.1206540","article-title":"Ceramide-mediated clustering is required for CD95-DISC formation","volume":"22","author":"Grassme","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41580-018-0046-6","article-title":"Author correction: sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0025","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1089\/ars.2017.7129","article-title":"Sphingolipids and redox signaling in renal regulation and chronic kidney diseases","volume":"28","author":"Bhat","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0030","first-page":"2511","article-title":"The complexity of sphingolipid biosynthesis in the endoplasmic reticulum","volume":"1833","author":"Tidhar","year":"2013","journal-title":"BBA"},{"key":"10.1016\/j.ijcha.2024.101469_b0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fcell.2019.00210","article-title":"Monitoring the sphingolipid de novo synthesis by stable-isotope labeling and liquid chromatography-mass spectrometry","volume":"7","author":"Wigger","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0040","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.emboj.7600034","article-title":"Identification of a family of animal sphingomyelin synthases","volume":"23","author":"Huitema","year":"2004","journal-title":"EMBO J."},{"issue":"44","key":"10.1016\/j.ijcha.2024.101469_b0050","doi-asserted-by":"crossref","first-page":"29971","DOI":"10.1074\/jbc.M805402200","article-title":"Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis","volume":"283","author":"Yabu","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12017-010-8132-8","article-title":"An introduction to sphingolipid metabolism and analysis by new technologies","volume":"12","author":"Chen","year":"2010","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.ijcha.2024.101469_b0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/metabo10090339","article-title":"Lipid Players of Cellular Senescence","volume":"10","author":"Millner","year":"2020","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0065","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcha.2024.101469_b0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yjmcc.2013.02.008","article-title":"Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy","volume":"59","author":"Maekawa","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcha.2024.101469_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2018.07.042","article-title":"Cross-platform metabolic profiling deciphering the potential targets of Shenfu injection against acute viral myocarditis in mice","volume":"160","author":"Tan","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijcha.2024.101469_b0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12017-010-8120-z","article-title":"Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses","volume":"12","author":"Wu","year":"2010","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.ijcha.2024.101469_b0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2013.00067","article-title":"Sphingolipid metabolism and obesity-induced inflammation","volume":"4","author":"Kang","year":"2013","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107734","article-title":"Role of ceramides in the pathogenesis of diabetes mellitus and its complications","volume":"35","author":"Mandal","year":"2021","journal-title":"J. Diabetes Compl."},{"key":"10.1016\/j.ijcha.2024.101469_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-020-01709-8","article-title":"Plasma sphingolipids and risk of cardiovascular diseases: a large-scale lipidomic analysis","volume":"16","author":"Seah","year":"2020","journal-title":"Metabolomics"},{"key":"10.1016\/j.ijcha.2024.101469_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10557-016-6651-8","article-title":"Identifying new risk markers and potential targets for coronary artery disease: the value of the lipidome and metabolome","volume":"30","author":"Laaksonen","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2015.03.011","article-title":"Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography","volume":"240","author":"Othman","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcha.2024.101469_b0110","unstructured":"In: Fuster V, Kelly BB, editors. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. The Collection: Reports funded by National Institutes of Health. Washington (DC), 2010."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0115","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI97949","article-title":"Role of sphingolipids in senescence: implication in aging and age-related diseases","volume":"128","author":"Trayssac","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0120","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.febslet.2010.02.026","article-title":"Ceramide-rich platforms in transmembrane signaling","volume":"584","author":"Stancevic","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijcha.2024.101469_b0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-015-0053-y","article-title":"Sphingolipids in cardiovascular diseases and metabolic disorders","volume":"14","author":"Borodzicz","year":"2015","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0130","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.biocel.2008.11.002","article-title":"Oxidized phospholipids: biomarker for cardiovascular diseases","volume":"41","author":"Ashraf","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41419-017-0257-3","article-title":"Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijcha.2024.101469_b0140","article-title":"Overview of OxLDL and its impact on cardiovascular health: focus on atherosclerosis","volume":"11","author":"Poznyak","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0145","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","article-title":"Sphingolipids contribute to human atherosclerotic plaque inflammation","volume":"36","author":"Edsfeldt","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcha.2024.101469_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.569250","article-title":"The role of ceramides in diabetes and cardiovascular disease regulation of ceramides by adipokines","volume":"11","author":"Field","year":"2020","journal-title":"Front Endocrinol. (Lausanne)."},{"issue":"18","key":"10.1016\/j.ijcha.2024.101469_b0155","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.1111\/jcmm.15744","article-title":"The role of sphingosine 1-phosphate and its receptors in cardiovascular diseases","volume":"24","author":"Ouyang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0160","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cbin.10991","article-title":"Sphingosine-1-phosphate promotes the proliferation and attenuates apoptosis of Endothelial progenitor cells via S1PR1\/S1PR3\/PI3K\/Akt pathway","volume":"42","author":"Wang","year":"2018","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/ATVBAHA.110.213496","article-title":"Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis","volume":"31","author":"Skoura","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1183\/09031936.00095609","article-title":"Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase","volume":"36","author":"Yang","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0175","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1523-1755.2002.00222.x","article-title":"Cross-talk between nitric oxide and superoxide determines ceramide formation and apoptosis in glomerular cells","volume":"61","author":"Pautz","year":"2002","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0180","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bph.13828","article-title":"Reactive oxygen species: key regulators in vascular health and diseases","volume":"175","author":"Chen","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.12997\/jla.2021.10.3.268","article-title":"The complex tail of circulating sphingolipids in atherosclerosis and cardiovascular disease","volume":"10","author":"Zelnik","year":"2021","journal-title":"J. Lipid Atheroscler."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2008.06.005","article-title":"Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice","volume":"58","author":"Park","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0195","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cellsig.2009.01.026","article-title":"Roles and regulation of secretory and lysosomal acid sphingomyelinase","volume":"21","author":"Jenkins","year":"2009","journal-title":"Cell. Signal."},{"issue":"19","key":"10.1016\/j.ijcha.2024.101469_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911948","article-title":"Sphingolipids in atherosclerosis: chimeras in structure and function","volume":"23","author":"Peters","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0205","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","article-title":"nSMase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by GW4869 reduces inflammation and atherosclerosis in apoe(-\/-) mice","volume":"38","author":"Lallemand","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"23","key":"10.1016\/j.ijcha.2024.101469_b0215","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.113.007559","article-title":"Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-\/- mice and rabbits fed a high-fat and -cholesterol diet","volume":"129","author":"Chatterjee","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0220","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1006\/bbrc.2002.6356","article-title":"Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids","volume":"290","author":"Garner","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0225","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/ATVBAHA.109.201673","article-title":"Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-\/- mice","volume":"30","author":"Bietrix","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0230","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1152\/ajpendo.91014.2008","article-title":"Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome","volume":"297","author":"Yang","year":"2009","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0235","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1038\/s41467-018-05613-7","article-title":"A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism","volume":"9","author":"Turner","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0240","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/CS20191028","article-title":"Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-\/- mice via reducing lipid uptake and vascular inflammation","volume":"134","author":"Yu","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0245","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.freeradbiomed.2012.05.026","article-title":"Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis","volume":"53","author":"Gao","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0250","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1055\/s-0038-1666870","article-title":"Elevating endogenous Sphingosine-1-Phosphate (S1P) levels improves endothelial function and ameliorates atherosclerosis in low density Lipoprotein Receptor-Deficient (LDL-R-\/-) Mice","volume":"118","author":"Feuerborn","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.ijcha.2024.101469_b0255","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1016\/j.febslet.2007.08.053","article-title":"Sphingosine 1-phosphate (S1P) inhibits monocyte-endothelial cell interaction by regulating of RhoA activity","volume":"581","author":"Tani","year":"2007","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0260","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.4049\/jimmunol.1201810","article-title":"Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3","volume":"190","author":"Lewis","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0265","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCRESAHA.110.235028","article-title":"Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte\/macrophages in inflammation and atherosclerosis","volume":"108","author":"Keul","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2024.101469_b0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.plipres.2018.12.002","article-title":"Cholesterol transport system: an integrated cholesterol transport model involved in atherosclerosis","volume":"73","author":"Yu","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ijcha.2024.101469_b0275","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/971453","article-title":"Emerging risk biomarkers in cardiovascular diseases and disorders","volume":"2015","author":"Upadhyay","year":"2015","journal-title":"J. Lipids."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tem.2022.02.001","article-title":"Lipids and lipoproteins in cardiovascular diseases: a classification","volume":"33","author":"Bhargava","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0285","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.ATV.0000112036.72200.ac","article-title":"Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase","volume":"24","author":"Kolmakova","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcha.2024.101469_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.841545","article-title":"Modified lipoproteins induce arterial wall inflammation during atherogenesis","volume":"9","author":"Lorey","year":"2022","journal-title":"Front Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0295","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.108.173344","article-title":"Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression","volume":"28","author":"Devlin","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"20","key":"10.1016\/j.ijcha.2024.101469_b0300","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s00018-011-0686-6","article-title":"Acid sphingomyelinase in macrophage biology","volume":"68","author":"Truman","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCRESAHA.109.194613","article-title":"Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice","volume":"105","author":"Liu","year":"2009","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0310","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/ATVBAHA.108.168682","article-title":"Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation","volume":"28","author":"Hailemariam","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0315","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1194\/jlr.M600040-JLR200","article-title":"Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice","volume":"47","author":"Dong","year":"2006","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0320","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/ATVBAHA.112.251538","article-title":"Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0325","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1476-5381.2009.00281.x","article-title":"Sphingolipids in inflammation: pathological implications and potential therapeutic targets","volume":"158","author":"Nixon","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcha.2024.101469_b0330","doi-asserted-by":"crossref","first-page":"4806541","DOI":"10.1155\/2017\/4806541","article-title":"The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer","volume":"2017","author":"Hait","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0335","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.ATV.0000019009.73586.7F","article-title":"Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1","volume":"22","author":"Viedt","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0340","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis","volume":"8","author":"Binder","year":"2002","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0345","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","article-title":"NLRP3 inflammasome in endothelial dysfunction","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0350","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0355","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1080\/15548627.2017.1393129","article-title":"CPTP: a sphingolipid transfer protein that regulates autophagy and inflammasome activation","volume":"14","author":"Mishra","year":"2018","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0360","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201142079","article-title":"Sphingosine regulates the NLRP3-inflammasome and IL-1beta release from macrophages","volume":"42","author":"Luheshi","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijcha.2024.101469_b0365","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.redox.2017.06.004","article-title":"Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia","volume":"13","author":"Koka","year":"2017","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0370","article-title":"Endothelial acid ceramidase in exosome-mediated release of NLRP3 inflammasome products during hyperglycemia: evidence from endothelium-specific deletion of Asah1 gene","volume":"1864","author":"Yuan","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ijcha.2024.101469_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.597423","article-title":"Reversal of endothelial extracellular vesicle-induced smooth muscle phenotype transition by hypercholesterolemia stimulation: role of NLRP3 inflammasome activation","volume":"8","author":"Yuan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0380","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0385","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0390","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3233\/JAD-160567","article-title":"Sphingolipid-enriched extracellular vesicles and Alzheimer's disease: a decade of research","volume":"60","author":"Dinkins","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0395","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrm3896","article-title":"Mechanotransduction and extracellular matrix homeostasis","volume":"15","author":"Humphrey","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"22","key":"10.1016\/j.ijcha.2024.101469_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225694","article-title":"The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes","volume":"20","author":"Jaminon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0405","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1194\/jlr.M700069-JLR200","article-title":"Neutral sphingomyelinase-induced ceramide triggers germinal vesicle breakdown and oxidant-dependent apoptosis in Xenopus laevis oocytes","volume":"48","author":"Coll","year":"2007","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0410","doi-asserted-by":"crossref","first-page":"e82379","DOI":"10.1371\/journal.pone.0082379","article-title":"Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling","volume":"8","author":"Liao","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0415","doi-asserted-by":"crossref","first-page":"487","DOI":"10.18097\/PBMC20186406487","article-title":"Lebedev capital A CTEC, Kurochkin IN. [The role of sphingolipids in cardiovascular pathologies]","volume":"64","author":"Alessenko","year":"2018","journal-title":"Biomed. Khim."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0420","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jcmm.14761","article-title":"Medial calcification in the arterial wall of smooth muscle cell-specific Smpd1 transgenic mice: a ceramide-mediated vasculopathy","volume":"24","author":"Bhat","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0425","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41598-020-58568-5","article-title":"Arterial medial calcification through enhanced small extracellular vesicle release in smooth muscle-specific asah1 gene knockout mice","volume":"10","author":"Bhat","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0430","doi-asserted-by":"crossref","first-page":"e21732","DOI":"10.1096\/fj.202100385R","article-title":"Regulatory role of mammalian target of rapamycin signaling in exosome secretion and osteogenic changes in smooth muscle cells lacking acid ceramidase gene","volume":"35","author":"Bhat","year":"2021","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0435","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.116.233205","article-title":"S1P signaling and de novo biosynthesis in blood pressure homeostasis","volume":"358","author":"Cantalupo","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0440","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2741\/4474","article-title":"Sphingolipids in obesity and related complications","volume":"22","author":"Boini","year":"2017","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0445","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcha.2024.101469_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104793","article-title":"Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology","volume":"156","author":"Jozefczuk","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0455","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/HYPERTENSIONAHA.110.162719","article-title":"Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension","volume":"57","author":"Yogi","year":"2011","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073796","article-title":"Differential expression of sphingolipid metabolizing enzymes in spontaneously hypertensive rats: a possible substrate for susceptibility to brain and kidney damage","volume":"22","author":"Pepe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052883","article-title":"Effect of empagliflozin on sphingolipid catabolism in diabetic and hypertensive rats","volume":"23","author":"Perez-Villavicencio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0470","first-page":"H605","article-title":"Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries","volume":"284","author":"Zhang","year":"2003","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"17","key":"10.1016\/j.ijcha.2024.101469_b0475","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.0000035650.05921.50","article-title":"Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0480","doi-asserted-by":"crossref","first-page":"e21817","DOI":"10.1371\/journal.pone.0021817","article-title":"Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide","volume":"6","author":"Spijkers","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0485","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156624","article-title":"Sortilin drives hypertension by modulating sphingolipid\/ceramide homeostasis and by triggering oxidative stress","volume":"132","author":"Varzideh","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0490","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/HYPERTENSIONAHA.119.14507","article-title":"Endothelial sphingolipid De Novo synthesis controls blood pressure by regulating signal transduction and NO via ceramide","volume":"75","author":"Cantalupo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcha.2024.101469_b0495","doi-asserted-by":"crossref","first-page":"44131","DOI":"10.1038\/srep44131","article-title":"Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction","volume":"7","author":"Siedlinski","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0500","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvw256","article-title":"Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension","volume":"113","author":"Meissner","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0505","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/HJH.0000000000002809","article-title":"Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice","volume":"39","author":"Hu","year":"2021","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0510","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11090645","article-title":"Metabolomics signature of plasma renin activity and linkage with blood pressure response to beta blockers and thiazide diuretics in hypertensive European American patients","volume":"11","author":"Mehanna","year":"2021","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0515","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/cvr\/cvac108","article-title":"Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure","volume":"119","author":"Sasset","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0520","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00395-012-0294-0","article-title":"Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat","volume":"107","author":"Knapp","year":"2012","journal-title":"Basic Res. Cardiol."},{"issue":"19","key":"10.1016\/j.ijcha.2024.101469_b0525","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.1074\/jbc.M112.428185","article-title":"Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties","volume":"288","author":"Russo","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0530","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.82922","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight."},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0535","doi-asserted-by":"crossref","first-page":"e1000672","DOI":"10.1371\/journal.pgen.1000672","article-title":"Genetic determinants of circulating sphingolipid concentrations in European populations","volume":"5","author":"Hicks","year":"2009","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0540","doi-asserted-by":"crossref","first-page":"172","DOI":"10.12997\/jla.2020.9.1.172","article-title":"Genetic architecture of circulating very-long-chain (C24:0 and C22:0) ceramide concentrations","volume":"9","author":"Cresci","year":"2020","journal-title":"J. Lipid Atheroscl."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0545","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacbts.2017.12.005","article-title":"Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction","volume":"3","author":"de Carvalho","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.ijcha.2024.101469_b0550","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.prostaglandins.2013.10.001","article-title":"Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction","volume":"106","author":"Knapp","year":"2013","journal-title":"Prostagl. Other Lipid Mediat."},{"issue":"14","key":"10.1016\/j.ijcha.2024.101469_b0555","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96203","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0560","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00395-016-0533-x","article-title":"Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury","volume":"111","author":"Reforgiato","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcha.2024.101469_b0565","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2016.02.019","article-title":"Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in the post-ischemic heart","volume":"93","author":"Klevstig","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcha.2024.101469_b0570","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1161\/CIRCULATIONAHA.112.107797","article-title":"Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers","volume":"125","author":"Mann","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0575","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1253\/circj.CJ-14-0178","article-title":"Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction","volume":"78","author":"Waeber","year":"2014","journal-title":"Circ J"},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0580","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","article-title":"Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction","volume":"141","author":"Hadas","year":"2020","journal-title":"Circulation"},{"issue":"43","key":"10.1016\/j.ijcha.2024.101469_b0585","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1093\/eurheartj\/ehab412","article-title":"Glucosylceramide synthase deficiency in the heart compromises beta1-adrenergic receptor trafficking","volume":"42","author":"Andersson","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0590","doi-asserted-by":"crossref","first-page":"e0129735","DOI":"10.1371\/journal.pone.0129735","article-title":"Targeted lipid profiling discovers plasma biomarkers of acute brain injury","volume":"10","author":"Sheth","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0595","first-page":"59","article-title":"Accumulation of ceramide in ischemic human brain of an acute case of cerebral occlusion","volume":"59","author":"Kubota","year":"1989","journal-title":"Jpn. J. Exp. Med."},{"issue":"2\u20133","key":"10.1016\/j.ijcha.2024.101469_b0600","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(00)01655-4","article-title":"Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus","volume":"296","author":"Nakane","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0605","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jnc.12836","article-title":"Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia","volume":"131","author":"Testai","year":"2014","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0610","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5650\/jos.60.537","article-title":"Structures, biosynthesis, and functions of gangliosides\u2013an overview","volume":"60","author":"Yu","year":"2011","journal-title":"J. Oleo Sci."},{"issue":"18","key":"10.1016\/j.ijcha.2024.101469_b0615","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1073\/pnas.92.18.8443","article-title":"Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity","volume":"92","author":"Tepper","year":"1995","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0620","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0968-0004(96)10056-6","article-title":"Sphingomyelin breakdown and cell fate","volume":"21","author":"Testi","year":"1996","journal-title":"Trends Biochem. Sci"},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0625","first-page":"1334","article-title":"Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death","volume":"1832","author":"Parra","year":"2013","journal-title":"BBA"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0630","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s003950170057","article-title":"Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats","volume":"96","author":"Zhang","year":"2001","journal-title":"Basic Res. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcha.2024.101469_b0635","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.CIR.0000143632.06471.93","article-title":"Sphingosine kinase activation mediates ischemic preconditioning in murine heart","volume":"110","author":"Jin","year":"2004","journal-title":"Circulation"},{"issue":"49","key":"10.1016\/j.ijcha.2024.101469_b0640","doi-asserted-by":"crossref","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","article-title":"Microenvironmental pH is a key factor for exosome traffic in tumor cells","volume":"284","author":"Parolini","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0645","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1073\/pnas.1818924116","article-title":"Temperature- and rigidity-mediated rapid transport of lipid nanovesicles in hydrogels","volume":"116","author":"Yu","year":"2019","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0650","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/0929866523666160427105138","article-title":"The influence of ionizing radiation on exosome composition, secretion and intercellular communication","volume":"23","author":"Jelonek","year":"2016","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijcha.2024.101469_b0655","first-page":"2","article-title":"Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress","author":"Kucharzewska","year":"2013","journal-title":"J. Extracell Vesicl."},{"key":"10.1016\/j.ijcha.2024.101469_b0660","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.plipres.2017.03.001","article-title":"Lipids in exosomes: Current knowledge and the way forward","volume":"66","author":"Skotland","year":"2017","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ijcha.2024.101469_b0665","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2016.10.011","article-title":"Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers","volume":"70","author":"Skotland","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0670","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-017-0706-8","article-title":"Role of exosomal proteins in cancer diagnosis","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Cancer"},{"issue":"43","key":"10.1016\/j.ijcha.2024.101469_b0675","doi-asserted-by":"crossref","first-page":"E8987","DOI":"10.1073\/pnas.1712108114","article-title":"Broad role for YBX1 in defining the small noncoding RNA composition of exosomes","volume":"114","author":"Shurtleff","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.ijcha.2024.101469_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109751","article-title":"Extracellular vesicle signalling in atherosclerosis","volume":"75","author":"Charla","year":"2020","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0685","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.shk.0000228791.10550.36","article-title":"Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury","volume":"26","author":"Densmore","year":"2006","journal-title":"Shock"},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b0690","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2337\/db15-1563","article-title":"Hsp20-mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice","volume":"65","author":"Wang","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0695","doi-asserted-by":"crossref","first-page":"16182","DOI":"10.1038\/s41598-020-73411-7","article-title":"Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia","volume":"10","author":"Burrello","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0700","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41598-022-09225-6","article-title":"Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy","volume":"12","author":"Timmerman","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0705","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jcp.21013","article-title":"T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor","volume":"212","author":"Zakharova","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0710","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115967","article-title":"Extracellular vesicles: versatile nanomediators, potential biomarkers and therapeutic agents in atherosclerosis and COVID-19-related thrombosis","volume":"22","author":"Georgescu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0715","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1194\/jlr.R083915","article-title":"Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles","volume":"59","author":"Verderio","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcha.2024.101469_b0720","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2017.04.067","article-title":"Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors","volume":"136","author":"Adachi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0725","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/CIRCRESAHA.116.305012","article-title":"Vascular smooth muscle cell calcification is mediated by regulated exosome secretion","volume":"116","author":"Kapustin","year":"2015","journal-title":"Circ. Res."},{"issue":"5867","key":"10.1016\/j.ijcha.2024.101469_b0730","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0735","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2337\/db13-1786","article-title":"New insight into early events in type 1 diabetes: role for islet stem cell exosomes","volume":"63","author":"Lukic","year":"2014","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0740","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cmet.2018.09.011","article-title":"Lymphocyte-derived exosomal MicroRNAs promote pancreatic beta cell death and may contribute to type 1 diabetes development","volume":"29","author":"Guay","year":"2019","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0745","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11892-017-0962-4","article-title":"Autoimmune responses to exosomes and candidate antigens contribute to type 1 diabetes in non-obese diabetic mice","volume":"17","author":"Dai","year":"2017","journal-title":"Curr. Diab. Rep."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0750","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/db16-0671","article-title":"Primary human and rat beta-cells release the intracellular autoantigens GAD65, IA-2, and proinsulin in exosomes together with cytokine-induced enhancers of immunity","volume":"66","author":"Cianciaruso","year":"2017","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0755","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1159\/000492252","article-title":"Adipocyte-derived exosomes carrying sonic hedgehog mediate M1 macrophage polarization-induced insulin resistance via Ptch and PI3K pathways","volume":"48","author":"Song","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0760","first-page":"2450","article-title":"Bone marrow mesenchymal stem cells-derived exosomal MiR-29b-3p regulates aging-associated insulin resistance","volume":"13","author":"Su","year":"2019","journal-title":"ACS Nano"},{"issue":"22","key":"10.1016\/j.ijcha.2024.101469_b0765","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1042\/CS20180487","article-title":"Human placental exosomes in gestational diabetes mellitus carry a specific set of miRNAs associated with skeletal muscle insulin sensitivity","volume":"132","author":"Nair","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b0770","first-page":"130","article-title":"Neutral ceramidase secreted via exosome protects against palmitate-induced apoptosis in INS-1 cells","volume":"125","author":"Tang","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0775","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ijcha.2024.101469_b0780","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bau103","article-title":"VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets","volume":"2014","author":"Qureshi","year":"2014","journal-title":"Database (Oxford)"},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0785","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrd3864","article-title":"MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles","volume":"11","author":"van Rooij","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0790","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/ATVBAHA.119.312707","article-title":"Extracellular MicroRNA-92a mediates endothelial cell-macrophage communication","volume":"39","author":"Chang","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0795","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/ATVBAHA.112.300279","article-title":"MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?","volume":"33","author":"Wei","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcha.2024.101469_b0800","doi-asserted-by":"crossref","first-page":"28627","DOI":"10.1038\/srep28627","article-title":"XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via extracellular vesicles","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0805","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1159\/000445588","article-title":"Thrombin stimulated platelet-derived exosomes inhibit platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells","volume":"38","author":"Tan","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0810","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/jpet.122.001253","article-title":"Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in coronavirus disease 2019 (COVID-19) patients: novel insights for long COVID metabolic sequelae","volume":"389","author":"Mone","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0815","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.122.001209","article-title":"Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19","volume":"384","author":"Gambardella","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b0820","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCRESAHA.113.300937","article-title":"MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms","volume":"112","author":"Goettsch","year":"2013","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0825","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1113\/JP271340","article-title":"Emerging roles for vascular smooth muscle cell exosomes in calcification and coagulation","volume":"594","author":"Kapustin","year":"2016","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0830","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14728222.2015.1081685","article-title":"Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification","volume":"20","author":"Henaut","year":"2016","journal-title":"Exp. Opin. Ther. Targets"},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0835","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1111\/jcmm.13692","article-title":"Exosomes, the message transporters in vascular calcification","volume":"22","author":"Zhang","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0840","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1113\/JP271338","article-title":"Extracellular vesicles in cardiovascular calcification: expanding current paradigms","volume":"594","author":"Krohn","year":"2016","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0845","first-page":"284","article-title":"Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation both in vitro and ex vivo","volume":"7","author":"Wang","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b0850","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2337\/db18-0470","article-title":"Circulating exosomal miR-20b-5p is elevated in type 2 diabetes and could impair insulin action in human skeletal muscle","volume":"68","author":"Katayama","year":"2019","journal-title":"Diabetes"},{"issue":"48","key":"10.1016\/j.ijcha.2024.101469_b0855","doi-asserted-by":"crossref","first-page":"12158","DOI":"10.1073\/pnas.1808855115","article-title":"Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice","volume":"115","author":"Castano","year":"2018","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0860","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jdiacomp.2016.07.012","article-title":"Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease","volume":"30","author":"Eissa","year":"2016","journal-title":"J. Diabetes Compl."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0865","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.18632\/aging.101689","article-title":"Injury factors alter miRNAs profiles of exosomes derived from islets and circulation","volume":"10","author":"Fu","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0870","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00125-018-4559-5","article-title":"Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes","volume":"61","author":"Lakhter","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0875","first-page":"709","article-title":"Potential value of urinary exosome-derived let-7c-5p in the diagnosis and progression of type II diabetic nephropathy","volume":"64","author":"Li","year":"2018","journal-title":"Clin. Lab."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0880","doi-asserted-by":"crossref","first-page":"e0154055","DOI":"10.1371\/journal.pone.0154055","article-title":"Urinary exosomal microRNA-451-5p is a potential early biomarker of diabetic nephropathy in rats","volume":"11","author":"Mohan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2024.101469_b0885","doi-asserted-by":"crossref","first-page":"6978984","DOI":"10.1155\/2017\/6978984","article-title":"Urinary exosomal MicroRNA profiling in incipient type 2 diabetic kidney disease","volume":"2017","author":"Xie","year":"2017","journal-title":"J. Diabetes Res."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b0890","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41423-020-0391-1","article-title":"The function and clinical application of extracellular vesicles in innate immune regulation","volume":"17","author":"Zhou","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0895","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41379-020-00661-1","article-title":"COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City","volume":"33","author":"Borczuk","year":"2020","journal-title":"Mod. Pathol."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b0900","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","article-title":"Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis","volume":"21","author":"Rodrigues","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"19","key":"10.1016\/j.ijcha.2024.101469_b0905","doi-asserted-by":"crossref","first-page":"2001467","DOI":"10.1002\/advs.202001467","article-title":"Multiresolution imaging using bioluminescence resonance energy transfer identifies distinct biodistribution profiles of extracellular vesicles and exomeres with redirected tropism","volume":"7","author":"Wu","year":"2020","journal-title":"Adv. Sci. (Weinh)."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b0910","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061190","article-title":"Manufacturing of human extracellular vesicle-based therapeutics for clinical use","volume":"18","author":"Gimona","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0915","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41587-019-0326-5","article-title":"Exosome redux","volume":"37","author":"Zipkin","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijcha.2024.101469_b0920","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Yanez-Mo","year":"2015","journal-title":"J. Extracell Vesicl."},{"key":"10.1016\/j.ijcha.2024.101469_b0925","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijcha.2024.101469_b0930","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yjmcc.2017.08.002","article-title":"Exosomes as agents of change in the cardiovascular system","volume":"111","author":"Poe","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0935","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.1038\/s41598-021-87939-9","article-title":"Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNA","volume":"11","author":"Walravens","year":"2021","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0269-4","article-title":"Macrophages in cardiac repair: environmental cues and therapeutic strategies","volume":"51","author":"de Couto","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0945","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0950","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010155","article-title":"Extracellular non-coding RNAs in cardiovascular diseases","volume":"15","author":"Jiapaer","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ijcha.2024.101469_b0955","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2021.07.042","article-title":"LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1\/PI3K\/AKT pathway","volume":"342","author":"Li","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b0960","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.joca.2016.06.022","article-title":"Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration","volume":"24","author":"Zhang","year":"2016","journal-title":"Osteoarthr. Cartil."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b0965","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"Ela","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b0970","doi-asserted-by":"crossref","first-page":"e0238879","DOI":"10.1371\/journal.pone.0238879","article-title":"Intravenous injection of extracellular vesicles to treat chronic myocardial ischemia","volume":"15","author":"Scrimgeour","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2024.101469_b0975","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/celldisc.2016.15","article-title":"Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity","volume":"2","author":"Sun","year":"2016","journal-title":"Cell Discov."},{"key":"10.1016\/j.ijcha.2024.101469_b0980","doi-asserted-by":"crossref","first-page":"7653489","DOI":"10.1155\/2016\/7653489","article-title":"Exosomes and their therapeutic potentials of stem cells","volume":"2016","author":"Han","year":"2016","journal-title":"Stem Cells Int."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b0985","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4252\/wjsc.v10.i8.106","article-title":"Stem cell-derived exosomes - an emerging tool for myocardial regeneration","volume":"10","author":"Lazar","year":"2018","journal-title":"World J. Stem Cells."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b0990","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1038\/s41598-018-27435-9","article-title":"GATA-4-expressing mouse bone marrow mesenchymal stem cells improve cardiac function after myocardial infarction via secreted exosomes","volume":"8","author":"He","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcha.2024.101469_b0995","doi-asserted-by":"crossref","first-page":"32993","DOI":"10.1038\/srep32993","article-title":"Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcha.2024.101469_b1000","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yjmcc.2018.04.012","article-title":"Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells","volume":"119","author":"Luther","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/HYPERTENSIONAHA.118.11239","article-title":"Angiotensin II-induced end-organ damage in mice is attenuated by human exosomes and by an exosomal Y RNA fragment","volume":"72","author":"Cambier","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b1010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.15252\/emmm.201606924","article-title":"Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion","volume":"9","author":"Cambier","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b1015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.healun.2016.01.013","article-title":"Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure","volume":"35","author":"Kervadec","year":"2016","journal-title":"J. Heart Lung Transpl."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2017.11.013","article-title":"The secret life of exosomes: what bees can teach us about next-generation therapeutics","volume":"71","author":"Marban","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b1025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2015.05.068","article-title":"Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-derived extracellular membrane vesicles","volume":"66","author":"Tseliou","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b1030","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1002\/jcb.26621","article-title":"Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA","volume":"119","author":"Namazi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"39","key":"10.1016\/j.ijcha.2024.101469_b1035","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/eurheartj\/ehx454","article-title":"Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats","volume":"38","author":"Grigorian-Shamagian","year":"2017","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b1040","doi-asserted-by":"crossref","first-page":"e2277","DOI":"10.1038\/cddis.2016.181","article-title":"Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4","volume":"7","author":"Xiao","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","article-title":"Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction","volume":"117","author":"Khan","year":"2015","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b1050","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"16","key":"10.1016\/j.ijcha.2024.101469_b1055","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.ijcha.2024.101469_b1060","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1001\/jama.2019.16585","article-title":"Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients at high risk for cardiovascular disease: the CLEAR wisdom randomized clinical trial","volume":"322","author":"Goldberg","year":"2019","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ijcha.2024.101469_b1070","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101469_b1075","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcha.2024.101469_b1080","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcha.2024.101469_b1085","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9860","key":"10.1016\/j.ijcha.2024.101469_b1095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b1100","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","article-title":"Sotagliflozin in patients with diabetes and chronic kidney disease","volume":"384","author":"Bhatt","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.2023.9696","article-title":"Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients","volume":"330","author":"Nissen","year":"2023","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcha.2024.101469_b1120","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcha.2024.101469_b1125","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/jama.2021.17992","article-title":"Clinical update on novel lipid-lowering therapies to reduce cardiovascular risk","volume":"326","author":"Ray","year":"2021","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-019-0864-7","volume":"18","author":"Fruchart","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b1135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.ijcha.2024.101469_b1140","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cvr\/cvp086","article-title":"Sphingosine-1-phosphate receptor signalling in the heart","volume":"82","author":"Means","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.119.13450","article-title":"Cardiovascular effects of pharmacological targeting of sphingosine kinase 1","volume":"75","author":"Jozefczuk","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOL.0000000000000802","article-title":"Links between ceramides and cardiac function","volume":"33","author":"Park","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1160","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/01.HYP.0000231507.00962.b5","article-title":"Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease","volume":"48","author":"Boulanger","year":"2006","journal-title":"Hypertension"},{"issue":"18","key":"10.1016\/j.ijcha.2024.101469_b1165","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.113.001720","article-title":"Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles","volume":"128","author":"Jansen","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b1170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"25","key":"10.1016\/j.ijcha.2024.101469_b1175","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcha.2024.101469_b1180","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/ATVBAHA.122.318048","article-title":"Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential","volume":"42","author":"Zietzer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.ijcha.2024.101469_b1185","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/ehq478","article-title":"Circulating CD31+\/Annexin V+ microparticles correlate with cardiovascular outcomes","volume":"32","author":"Sinning","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2024.101469_b1190","doi-asserted-by":"crossref","first-page":"25625","DOI":"10.3402\/jev.v3.25625","article-title":"Levels of procoagulant microvesicles are elevated after traumatic injury and platelet microvesicles are negatively correlated with mortality","volume":"3","author":"Curry","year":"2014","journal-title":"J. Extracell Vesicl."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b1195","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ncb2441","article-title":"Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs","volume":"14","author":"Hergenreider","year":"2012","journal-title":"Nat. Cell Biol."},{"issue":"11 Suppl 1","key":"10.1016\/j.ijcha.2024.101469_b1200","first-page":"S81","article-title":"MicroRNA-145 targeted therapy reduces atherosclerosis","volume":"126","author":"Lovren","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b1205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2019.02.005","article-title":"Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE(-\/-) mice via miR-let7 mediated infiltration and polarization of M2 macrophage","volume":"510","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b1210","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.18632\/aging.102857","article-title":"Adipose-derived mesenchymal stem cells-derived exosome-mediated microRNA-342-5p protects endothelial cells against atherosclerosis","volume":"12","author":"Xing","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101469_b1215","doi-asserted-by":"crossref","first-page":"e12648","DOI":"10.1111\/sji.12648","article-title":"Endothelial extracellular vesicles modulate the macrophage phenotype: potential implications in atherosclerosis","volume":"87","author":"He","year":"2018","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101469_b1220","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCRESAHA.114.302213","article-title":"Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice","volume":"114","author":"Loyer","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b1225","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ymthe.2017.03.031","article-title":"Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis","volume":"25","author":"Zheng","year":"2017","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.ijcha.2024.101469_b1230","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.7150\/thno.37357","article-title":"Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p\/PTEN-mediated VSMC migration and proliferation","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics."},{"issue":"12","key":"10.1016\/j.ijcha.2024.101469_b1235","first-page":"7039","article-title":"Exosome-mediated miR-106a-3p derived from ox-LDL exposed macrophages accelerated cell proliferation and repressed cell apoptosis of human vascular smooth muscle cells","volume":"24","author":"Liu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101469_b1240","first-page":"5315","article-title":"Dendritic cell exosome-shuttled miRNA146a regulates exosome-induced endothelial cell inflammation by inhibiting IRAK-1: a feedback control mechanism","volume":"20","author":"Zhong","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ijcha.2024.101469_b1245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2017.04.016","article-title":"Thrombin-activated platelet-derived exosomes regulate endothelial cell expression of ICAM-1 via microRNA-223 during the thrombosis-inflammation response","volume":"154","author":"Li","year":"2017","journal-title":"Thromb. Res."},{"issue":"22","key":"10.1016\/j.ijcha.2024.101469_b1250","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.7150\/thno.28021","article-title":"Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction","volume":"8","author":"Zhu","year":"2018","journal-title":"Theranostics."},{"issue":"493","key":"10.1016\/j.ijcha.2024.101469_b1255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau1168","article-title":"Circulating exosomes derived from transplanted progenitor cells aid the functional recovery of ischemic myocardium","volume":"11","author":"Saha","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b1260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/1354750X.2020.1803963","article-title":"Serum exosomal miR-122-5p is a new biomarker for both acute coronary syndrome and underlying coronary artery stenosis","volume":"25","author":"Ling","year":"2020","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5966\/sctm.2015-0386","article-title":"Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal MicroRNA-21","volume":"6","author":"Wang","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2019.04.138","article-title":"Exosomal miR-301 derived from mesenchymal stem cells protects myocardial infarction by inhibiting myocardial autophagy","volume":"514","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b1275","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-020-2545-6","article-title":"Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13287-020-1563-8","article-title":"Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN\/AKT pathway","volume":"11","author":"Wen","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b1285","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/cvr\/cvy231","article-title":"microRNA-423-3p exosomes derived from cardiac fibroblasts mediates the cardioprotective effects of ischaemic post-conditioning","volume":"115","author":"Luo","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2024.101469_b1290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2019.02.002","article-title":"Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN\/PI3K\/AKT signaling pathway","volume":"177","author":"Sun","year":"2019","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.ijcha.2024.101469_b1295","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/cvr\/cvz040","article-title":"Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization","volume":"115","author":"Zhao","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2024.101469_b1300","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.gene.2018.12.044","article-title":"Exosomes derived miR-126 attenuates oxidative stress and apoptosis from ischemia and reperfusion injury by targeting ERRFI1","volume":"690","author":"Wang","year":"2019","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1305","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1038\/s41467-020-17273-7","article-title":"Author Correction: therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension","volume":"11","author":"Sindi","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101469_b1310","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1165\/rcmb.2019-0154OC","article-title":"Mesenchymal stem cell extracellular vesicles reverse sugen\/hypoxia pulmonary hypertension in rats","volume":"62","author":"Klinger","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101469_b1315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10565-024-09879-0","article-title":"Exosomes enriched by miR-429-3p derived from ITGB1 modified Telocytes alleviates hypoxia-induced pulmonary arterial hypertension through regulating Rac1 expression","volume":"40","author":"Qi","year":"2024","journal-title":"Cell Biol. Toxicol."},{"issue":"15","key":"10.1016\/j.ijcha.2024.101469_b1320","first-page":"8087","article-title":"Up-regulation of exosomal miR-106a may play a significant role in abdominal aortic aneurysm by inducing vascular smooth muscle cell apoptosis and targeting TIMP-2, an inhibitor of metallopeptidases that suppresses extracellular matrix degradation","volume":"24","author":"Han","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijcha.2024.101469_b1325","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1038\/ncomms6214","article-title":"miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development","volume":"5","author":"Maegdefessel","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijcha.2024.101469_b1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155274","article-title":"MicroRNA-155 and exosomal microRNA-155: small pieces in the cardiovascular diseases puzzle","volume":"257","author":"Eshraghi","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ijcha.2024.101469_b1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105645","article-title":"Differentially expressed microRNA profiles in exosomes from vascular smooth muscle cells associated with coronary artery calcification","volume":"118","author":"Pan","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101469_b1340","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/labinvest.2012.85","article-title":"MicroRNAs that target Ca(2+) transporters are involved in vascular smooth muscle cell calcification","volume":"92","author":"Gui","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ijcha.2024.101469_b1345","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/624037","article-title":"Runx2\/miR-3960\/miR-2861 positive feedback loop is responsible for osteogenic transdifferentiation of vascular smooth muscle cells","volume":"2015","author":"Xia","year":"2015","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1350","first-page":"429","article-title":"Inhibition of miR-155-5p attenuates the valvular damage induced by rheumatic heart disease","volume":"45","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101469_b1355","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.kjms.2018.05.008","article-title":"Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure","volume":"34","author":"Wang","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101469_b1360","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13266","article-title":"BMSC-derived exosome-mediated miR-25-3p delivery protects against myocardial ischemia\/reperfusion injury by constraining M1-like macrophage polarization","volume":"30","author":"Du","year":"2024","journal-title":"Mol. Med. Rep."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T16:51:11Z","timestamp":1733590271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906724001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":272,"alternative-id":["S2352906724001350"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101469","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101469"}}